Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyrazine SCHEMBL28078427 | 1.00 | ALDH1A1 (0.87) | ALDH1A1FKBP5 | |
| Imidazole SCHEMBL28744226 | 0.93 | ALDH1A1 (1.00) | ALDH1A1FKBP5 | |
| Imidazole SCHEMBL1331920 | 0.93 | — | — | |
| Imidazole SCHEMBL19028065 | 0.93 | ALDH1A1 (1.00) | ALDH1A1FKBP5 | |
| Imidazole SCHEMBL2684565 | 0.93 | ALDH1A1 (1.00) | ALDH1A1FKBP5 | |
| Imidazole SCHEMBL30382963 | 0.93 | — | — | |
| Imidazole SCHEMBL1331382 | 0.93 | — | — | |
| Imidazole SCHEMBL897 | 0.93 | — | — | |
| Imidazole SCHEMBL2635292 | 0.93 | — | — | |
| Pyrazine SCHEMBL8970869 | 0.91 | ALDH1A1 (0.72) | ALDH1A1FKBP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 655 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112018248-B | Display device and preparation method thereof | 固安鼎材科技有限公司 | 2023-12-29 | — | — | CN | claimed |
| US-20220119270-A1 | CERIA NANOPARTICLES AND CERIA NANOPARTICLES PREPARATION METHOD | Research & Business Foundation Sungkyunkwan University (KR) | 2022-04-21 | — | — | US | claimed |
| CN-106715420-A | crosslinkable host material | 西诺拉股份有限公司 | 2017-05-24 | — | — | CN | claimed |
| CN-106084187-A | Polymer, crosslinked polymer and the electroluminescent device comprising described polymer | 默克专利有限公司 | 2016-11-09 | — | — | CN | claimed |
| CN-103980281-B | A kind of imidazoles pyrazine compound and preparation method thereof | 天津市斯芬克司药物研发有限公司 | 2016-06-08 | — | — | CN | claimed |
| CN-103980281-A | Imidazole pyrazine compound and preparation method thereof | SPHINX SCIENT LAB CORP | 2014-08-13 | — | — | CN | claimed |
| EP-1027713-A4 | NONAQUEOUS ELECTROLYTE FOR ELECTRICAL STORAGE DEVICES | COVALENT ASSOCIATES INC (US) | 2004-08-11 | — | — | EP | claimed |
| EP-1232206-A1 | ANTISTATIC COMPOSITION | 3M Innovative Properties Company (US) | 2002-08-21 | — | — | EP | claimed |
| WO-2001025326-A1 | ANTISTATIC COMPOSITION | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2001-04-12 | — | — | WO | claimed |
| EP-1027713-A1 | NONAQUEOUS ELECTROLYTE FOR ELECTRICAL STORAGE DEVICES | COVALENT ASSOCIATES INCORPORATED (US) | 2000-08-16 | — | — | EP | claimed |
| WO-1999008299-A1 | NONAQUEOUS ELECTROLYTE FOR ELECTRICAL STORAGE DEVICES | COVALENT ASSOCIATES, INC. (US) | 1999-02-18 | — | — | WO | claimed |
| EP-0042210-B1 | PALLADIUM(II) BIS (HEXAFLUOROACETYLACETONATE), ADDUCTS DERIVED THEREFROM AND USES THEREOF | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1984-08-01 | — | — | EP | claimed |
| JP-1040940-A | — | — | None | — | — | JP | disclosed |
| JP-5323550-A | — | — | None | — | — | JP | disclosed |
| CN-118339510-A | Liquid crystal display device | 默克专利股份有限公司 | 2024-07-12 | — | — | CN | disclosed |
| US-20240199616-A1 | BICYCLIC COMPOUNDS AS ALLOSTERIC SHP2 INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT | 2024-06-20 | — | — | US | disclosed |
| US-4362806-A | PHOTOGRAPHY, SILVER HALIDE EMULSIONS | EASTMAN KODAK COMPANY (US) | 1982-12-07 | — | — | US | disclosed |
| US-4269927-A | DOPED WITH CADMIUM, LEAD, COPPER, OR ZINC OR MIXTURES; HIGH SPEED COLOR FILMS; LOW CONCENTRATION OF SILVER IODIDE | EASTMAN KODAK COMPANY (US) | 1981-05-26 | — | — | US | disclosed |
| US-4269914-A | INCLUDING A LAYER TO RECEIVE AND IMMOBILIZE A DIFFUSIBLE DESENSITIZER ABLE TO EFFECT THE SENSITIVITY OF A SILVER HALIDE EMULSION TO ELECTROMAGNETIC RADIATION AND A BARRIER LAYER | EASTMAN KODAK COMPANY (US) | 1981-05-26 | — | — | US | disclosed |
| EP-0017148-A1 | Internally doped high chloride silver halide emulsions, processes for their preparation and photographic elements | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1980-10-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240199616-A1 | BICYCLIC COMPOUNDS AS ALLOSTERIC SHP2 INHIBITORS | PTPN18, PTPN1, PTPN2 | ALDH1A1 4439/4885FKBP5 1246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.